Baseline Systemic Oral Corticosteroid Use in Patients with Asthma Initiating Dupilumab Treatment in the Real World: From the RAPID Global Registry
J Asthma Allergy
.
2024 Jun 6:17:551-556.
doi: 10.2147/JAA.S451689.
eCollection 2024.
Authors
Nijra L Lugogo
1
,
Enrico Heffler
2
3
,
Vicente Plaza
4
,
Ole Hilberg
5
,
Changming Xia
6
,
Scott Nash
6
,
Nami Pandit
7
,
Juby A Jacob-Nara
7
,
Harry J Sacks
6
,
Paul J Rowe
7
,
Yamo Deniz
6
,
Megan Hardin
8
,
Xavier Soler
6
Affiliations
1
University of Michigan Medical School, Ann Arbor, MI, USA.
2
IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.
3
Humanitas University, Pieve Emanuele, Milan, Italy.
4
Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
5
Lillebaelt Hospital, Vejle, Denmark.
6
Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA.
7
Sanofi, Bridgewater, NJ, USA.
8
Sanofi, Cambridge, MA, USA.
PMID:
38860029
PMCID:
PMC11164082
DOI:
10.2147/JAA.S451689
No abstract available
Grants and funding
This research was sponsored by Sanofi and Regeneron Pharmaceuticals Inc., ClinicalTrials.gov Identifier: NCT04287621.